;



STRATIFYRx LLP is a next-generation pharmaceutical innovation and consulting company. We focus on:
• Strategic product development that identifies market gaps and patient needs.
• IP-centric innovation that ensures long-term value creation and protection.
• Global market readiness through partnerships with R&D labs, CDMOs, CROs, and commercialization experts.
Our mission is to deliver safe, convenient, and effective therapies that improve patient quality of life—without the high costs or risks of traditional pharma models.
We identify unmet clinical and commercial needs and translate them into viable development opportunities.
We craft regulatory and formulation roadmaps that de-risk projects and accelerate timelines.
Through our global network of R&D labs, CROs, and CDMOs, we ensure smooth scale-up and compliant tech-transfer.
We design filing strategies and IP protections that maximize market access and lifecycle value.
Our milestone-based execution models give investors and innovators flexibility with reduced risk.
Lorem ipsum dolor sit elit consectur sed eiusmod tempor labore set aliquat enim minim.
We bring innovation without the overhead of owning facilities, leveraging world-class partners instead.
Every project is designed to maximize long-term value and protect competitive advantage.
With partners across US, EU, and Asia, we ensure regulatory and market adaptability from day one.
Milestone-driven project management keeps development lean, agile, and investor-friendly.
Our curated partnerships with R&D labs, CDMOs, CROs, and commercialization leaders provide end-to-end solutions.


Patient-friendly delivery for complex therapies.
Innovative dosage forms to improve adherence.
Safer, targeted approaches for acute and chronic pain.
Enhancing patient comfort during oncology and chronic treatments.
Smart formulations to combat resistance and improve treatment outcomes.
Smart formulations to combat resistance and improve treatment outcomes.
We believe great ideas deserve world-class execution. STRATIFYRx connects innovators to:
• Partner R&D laboratories for early formulation work
• CROs for preclinical and clinical studies
• cGMP CDMOs for scale-up and commercial manufacturing
• Regulatory and IP experts for filing support and lifecycle management
• Commercialization partners for US, EU, and global market access

